CASP9 and cancer: To conclude, LINC00607 could facilitate a novel aspect of the treatment for patients with TC where the decreased methylation of CASP9 gene promoter, accelerated the apoptosis period of TC and reduced the level of resistance in cancer cells (Figure 8).